About the Company
We do not have any company description for HeartSciences Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on HeartSciences Inc.
HeartSciences Announces Conference Participation and Investor Webinar
Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or ...
HeartSciences Inc. Reports Q2 FY2025 Financial Results and ... - Nasdaq
HeartSciences Inc., a medical technology company specializing in AI-powered ECG solutions, reported significant progress in its second quarter fiscal 2025 ending October 31, 2024.
HeartSciences Inc. Reports Fiscal Year 2025 Financial Results and ...
HeartSciences Inc., an AI-driven medical technology company, reported its financial results for the fiscal year ending April 30, 2025, and highlighted its strategic advancements in transforming ...
Foundational US Patent Granted for ECG Assessment of Heart Function ...
To date HeartSciences has been granted 10 US patents and 34 international patents for a total of 44 granted patents. Issued international patents are across key countries including China, Brazil ...
HeartSciences Inc. (HSCSW) latest stock news and headlines – Yahoo ...
Southlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company ...
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14 ...
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on ...
HeartSciences Inc. Engages Integrous Communications to Enhance Investor ...
Southlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company ...
HSCSW HeartSciences Inc. WT EXP 061527 - Seeking Alpha
HeartSciences Inc. WT EXP 061527 SEC Filing - Securities Registration Statement (S-1/A) September 27, 2024 SEC FilingsFri, Sep. 27, 2024 ...
EXCLUSIVE: HeartSciences Announces Expansion of Artificial ... - Benzinga
Heart Test Laboratories Inc d/b/a HeartSciences HSCS has been issued a notice of patent allowance from the European Patent Office. To date, HeartSciences has been granted or allowed 41 patents ...
HeartSciences Inc. Engages Integrous ... - The Globe and Mail
Potential risks and uncertainties include, but are not limited to, risks discussed in HeartSciences' Annual Report on Form 10-K for the fiscal year ended April 30, 2024, filed with the U.S ...
HeartSciences Inc.: HeartSciences Receives FDA Breakthrough Device ...
Potential risks and uncertainties include, but are not limited to, risks discussed in HeartSciences' Annual Report on Form 10-K for the fiscal year ended April 30, 2024, filed with the U.S ...
HeartSciences Inc. Engages Integrous ... - The Globe and Mail
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications Heart Test Laboratories, Inc. - GlobeNewswire - Mon Mar 10, 8:00AM CDT ...
Similar Companies
Loading the latest forecasts...